Mini protocol sketch: all subjects sign consent, complete screening, and if eligible are randomized to Drug A or placebo. They then have treatment visits and a follow-up period. Before looking at any actual subject dates, a reviewer wants a structured picture of that planned path. Which content belongs in Trial Design datasets?